She credits her doctors at University Hospitals for their thoroughness in finding the hidden tumor that was up against her chest wall. They suggested an MRI after the mammogram and ultrasound couldn't give them a definite answer.
Sharon required a lumpectomy and six weeks of radiation treatment and advises other women to be vigilant.
"Don't neglect your health, your health is your wealth you must get your checkups and you must get your annual mammograms," Sharon says.
Sharon's doctors recommended a test called an Oncotype DX. It's a test that examines a breast cancer patient's tumor tissue at a molecular level and gives information about her particular disease.
The purpose is to help design proper treatment. It is also used to determine if a patient would benefit from chemotherapy and if she has a high risk of recurrence.
The Oncotype DX is intended for women with early-stage lymph node-negative, estrogen receptor positive invasive breast cancer who will be treated with hormone therapy.